A Study of Physical Activity in Cancer Survivors
Overview
Tab Title Description
Study type
InterventionalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Mankato, Minnesota: 23-001462
- Eau Claire, Wisconsin: 23-001462
- La Crosse, Wisconsin: 23-001462
- Albert Lea, Minnesota: 23-001462
NCT ID: NCT05988892
Sponsor Protocol Number: 23-001462
About this study
The purpose of this study is to determine if to increasing physical activity (PA) will increase physical functioning, as measured by cardiovascular endurance, muscular strength, and balance in underserved adult cancer survivors of ages 18 or older residing at a rural address. Also, to deternube if increasing PA will increase quality of life (QOL), as measured by physical functioning and fatigue, in underserved cancer survivors ages 18 or older residing at a rural address.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria:
* Adult, cancer survivors (no active disease) at Mayo Clinic Health System (MCHS) in Northwest Wisconsin (NWWI), Southwest Wisconsin (SWWI), Southeast Minnesota (SEMN), or Southwest Minnesota (SWMN)
* Any stage cancer
* Age ≥18 years residing at a rural address (as defined by Rural America, census.gov)
* Completed active treatment of surgery, (neo)adjuvant chemotherapy, and/or (neo) adjuvant radiation. Patients receiving adjuvant endocrine therapy, targeted therapy, or immunotherapy therapies are eligible.
* Ownership of a computer/tablet/smartphone with internet access.
* Willingness to create a google account and maintain the account for use of the Fitbit
* Willingness and ability to attend study visits.
* Must be able to complete semi-tandem (10 seconds), side-by-side tandem \[10 seconds and short physical performance batters(SPPB)\] Score of 6 or greater to qualify for virtual exercise.
* Must be ambulatory without the use of assisted device(s).
Exclusion Criteria:
* Receiving surgery, (neo)adjuvant chemotherapy, (neo) adjuvant radiation, palliative treatment
* Are already performing \>150 minutes/week of moderate activity or 75 min/week of vigorous physical activity
* Cancer-free for greater than 5 years
* Unable to complete weekly interventions/exercise due to traveling or unable to be active for more than 7 consecutive days.
Note: Other protocol defined Inclusion/Exclusion Criteria may apply.
Eligibility last updated 12/31/2024. Questions regarding updates should be directed to the study team contact.
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
Contact |
Mankato, Minn.
Mayo Clinic principal investigator Tamara OBrien, APRN, C.N.P., M.S.N. |
Closed for enrollment |
Contact information:
Cancer Center Clinical Trials Referral Office
(855) 776-0015
|
Eau Claire, Wis.
Mayo Clinic principal investigator Kaye Sturz, C.N.P., A.P.N.P., M.S. |
Closed for enrollment |
Contact information:
Cancer Center Clinical Trials Referral Office
(855) 776-0015
|
La Crosse, Wis.
Mayo Clinic principal investigator Emily Stewart, P.A.-C., P.A. |
Closed for enrollment |
Contact information:
Cancer Center Clinical Trials Referral Office
(855) 776-0015
|
Albert Lea, Minn.
Mayo Clinic principal investigator Sydney Schone, APRN, C.N.P., D.N.P. |
Closed for enrollment |
Contact information:
Cancer Center Clinical Trials Referral Office
(855) 776-0015
|
More information
Publications
Publications are currently not available